The value of blood cytokines and chemokines in assessing COPD

BACKGROUND: Blood biomarkers are increasingly used to stratify high risk chronic obstructive pulmonary disease (COPD) patients; however, there are fewer studies that have investigated multiple biomarkers and replicated in multiple large well-characterized cohorts of susceptible current and former sm...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradford, Eric, Jacobson, Sean, Varasteh, Jason, Comellas, Alejandro P., Woodruff, Prescott, O’Neal, Wanda, DeMeo, Dawn L., Li, Xingnan, Kim, Victor, Cho, Michael, Castaldi, Peter J., Hersh, Craig, Silverman, Edwin K., Crapo, James D., Kechris, Katerina, Bowler, Russell P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655820/
https://www.ncbi.nlm.nih.gov/pubmed/29065892
http://dx.doi.org/10.1186/s12931-017-0662-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655820/
https://www.ncbi.nlm.nih.gov/pubmed/29065892
http://dx.doi.org/10.1186/s12931-017-0662-2

Ejemplares similares